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Background
Children with Down's syndrome are known to develop
inflammatory arthritis with a prevalence thought to be
greater than the general population [1]. Despite this, the
diagnosis is still being overlooked leading to delayed
treatment and poor outcomes.
Cases
We describe 8 cases, 4 females with an age range of 4.2 –
15.6 (mean 9.3) years at diagnosis. Time from symptom
onset to diagnosis ranged from 0.9 – 8.7 (mean 3.3) years,
despite attending up to 16 (mean 6.2) clinics with docu-
mented symptoms and signs of arthritis. Misdiagnoses
included developmental delay, soft tissue injury, hyper-
mobility, multiple epiphyseal dysplasia and behavioural
problems. All had a clear clinical diagnosis of polyarticu-
lar arthritis and four where non-weight bearing at first
contact with paediatric rheumatology. Two patients had
psoriasis. One patient had psoriatic nail changes. Five had
a family history of rheumatological disease. All were anti-
nuclear antibody negative. All were treated with intraartic-
ular steroid injections. All were offered methotrexate and
five clinically responded. Of the three who did not toler-
ate methotrexate, two were offered and improved with
etanercept.
Conclusion
Diagnosis of arthritis in children with Down's syndrome
is still significantly delayed compared to other children
presenting with inflammatory arthritis. In our cohort,
response to treatment was similar to children with juve-
nile idiopathic arthritis (JIA). Current evidence suggests
response to treatment in JIA is optimal when commenced
early. Many of this cohort had significant joint damage
and disability by time of diagnosis. Delays in diagnosis
are contributing to unnecessary disability in this group of
children.
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